Trials / Conditions / Treatment Resistant Major Depressive Disorder

Treatment Resistant Major Depressive Disorder

14 registered clinical trials studyying Treatment Resistant Major Depressive Disorder — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Understanding Music and Mindfulness Preferences in Psilocybin-Assisted Psychotherapy NCT07373535	Kyle Greenway	Phase 2
Recruiting	Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression NCT07422519	Hospital Universitari Vall d'Hebron Research Institute	N/A
Not Yet Recruiting	Triple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Ad NCT07052058	Hospital de Clinicas de Porto Alegre	Phase 2
Recruiting	Personalized Ultrasonic Brain Stimulation for Depression (R61) NCT06902298	Brian Mickey	Phase 1 / Phase 2
Recruiting	Digital Interventions for Adults with Treatment-Resistant Depression: a Pilot Study NCT06732089	Unity Health Toronto	—
Active Not Recruiting	Avatar Therapy in Virtual Reality for Treatment-Resistant Major Depressive Disorder: A Pilot Study NCT07112261	Ciusss de L'Est de l'Île de Montréal	N/A
Withdrawn	Repeated Intranasal Esketamine Plus Almond Therapy in Participants With Treatment Resistant Depressive Disorde NCT05438758	Zylorion Health	Phase 2
Terminated	Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression NCT05323019	Zylorion Health	Phase 2
Withdrawn	The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD NCT05381974	Massachusetts General Hospital	Phase 2
Terminated	Remotely Programmed Deep Brain Stimulation of the Bilateral Habenula for Treatment- Resistant Major Depression NCT03254017	Ruijin Hospital	N/A
Completed	Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD NCT02977299	Massachusetts General Hospital	Phase 4
Completed	A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Diso NCT02741791	Axsome Therapeutics, Inc.	Phase 3
Active Not Recruiting	DBS of the Lateral Habenula in Treatment-Resistant Depression NCT01798407	Wayne Goodman MD	N/A
Completed	This is a Study to Determine the Antidepressant Effects of AZD6765 NCT00986479	AstraZeneca	Phase 2